NYSE: CHE · Industrial Applications and Services · 7 alerts · CIK 19584
Share price
$549.45Close, Nov 16
Market cap
$7.15B
Shares outstanding
13.01MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Home Health Care ServicesSIC 8082
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Chemed Corp filings on SEC EDGAR ↗
Spencer S. Lee, EVP, sold 1,000 shares of Chemed Corp at $547.61 a share, worth $548K in total on Nov 11, 2026. Shares held after the trade: 12,931 (-7.2%).
Chemed president and CEO Kevin J. Mcnamara Sells $1.08M of Stock
Kevin J. Mcnamara, president and CEO, sold 2,000 shares of Chemed Corp at $537.90 a share, worth $1.08M in total on Nov 3, 2026. Shares held after the trade: 82,220 (-2.4%).
Spencer S. Lee, EVP, sold 920 shares of Chemed Corp at $537.17 a share, worth $494K in total on Nov 2, 2026. Shares held after the trade: 13,931 (-6.2%).
Chemed Corp reported a net income of $71.6 million for the third quarter of 2026, up from $64.2 million in the prior year, driven by service revenues of $690.9 million. For the nine months ended September 30, 2026, net income reached $205.7 million, while the company significantly increased its long-term debt to $236 million and expanded its goodwill through business combinations.
Chemed Corporation reported third-quarter 2026 consolidated revenue of $690.9 million, a 10.6% increase year-over-year, driven by strong performance in its VITAS Healthcare segment. GAAP diluted EPS rose 22.2% to $5.45, while the VITAS segment saw a 12.2% increase in net patient revenue and a significant expansion in Adjusted EBITDA margins.